---
title: "Alexion Pharmaceuticals, Inc. v Amgen Technology (Ireland) Unlimited Company and others (UPC CoA 405/2024, 20-12-2024)"
description: "The Court of Appeal rejected Alexion's appeal, so no provisional measures will be ordered against Amgen's eculizumab biosimilar BEKEMV®."
url: https://pitch.law/academy/upc-court-of-appeal/upc-coa-405-2024-2024-12-20
lang: en
author: "UPC Case Law by Pitch"
editor: "Bart Lieben"
datePublished: 2026-11-18T10:07:16.462Z
dateModified: 2026-11-18T10:07:16.462Z
---

# Alexion Pharmaceuticals, Inc. v Amgen Technology (Ireland) Unlimited Company and others

Order of the UPC Court of Appeal of 20 December 2024, UPC CoA 405/2024.

UPC Case Law by Pitch, edited by [Bart Lieben](https://pitch.law/team/bart-lieben) · Published 18-11-2026

## TL;DR

The Court of Appeal rejected Alexion's appeal, so no provisional measures will be ordered against Amgen's eculizumab biosimilar BEKEMV®. Claim 2 of EP 3167888 had to be read literally, including 22 extra amino acids that Alexion said were an obvious error, and on that reading the claim is more likely than not insufficiently disclosed. The order sets a strict test for correcting errors in a claim by interpretation and confirms that statements made during grant can show how the skilled person reads the claim.

## Key holding

A linguistic error, spelling mistake or other inaccuracy in a patent claim can only be corrected by interpretation if both the existence of the error and the precise way to correct it are sufficiently certain to the average skilled person. That certainty must come from the claim, read with the description and drawings and using common general knowledge. The patentee's assertions during grant proceedings, and especially a Technical Board of Appeal's endorsement of them, can indicate how the skilled person understood the claim at the filing date.

## Questions decided

1. When can an error in a patent claim be corrected by way of claim interpretation?
2. Can statements made by the applicant during EPO grant proceedings inform claim interpretation?
3. Does a merely statistical prediction of a signal-peptide cleavage site make a correction sufficiently certain?
4. Is validity sufficiently certain for provisional measures where the claim as properly read is likely insufficiently disclosed under Art 83 EPC?

## Case details

- Court: Court of Appeal of the Unified Patent Court, Panel 1a
- Panel: Klaus Grabinski (President of the Court of Appeal); Peter Blok (legally qualified judge and judge-rapporteur); Emmanuel Gougé (legally qualified judge); Eric Enderlin (technically qualified judge); Anna Hedberg (technically qualified judge)
- Date: 20-12-2024
- Case number(s): UPC CoA 405/2024, UPC CFI 124/2024
- Parties: Appellant: Alexion Pharmaceuticals, Inc. (applicant at first instance); Respondents: Amgen Technology (Ireland) Unlimited Company, Amgen N.V., Amgen GmbH (Munich), Amgen GmbH (Vienna), Amgen AB, Amgen S.A.S., Amgen s.r.l., Amgen Biofarmacêutica Lda. and Amgen Zdravila D.O.O. (defendants at first instance)
- Language of the proceedings: English
- Outcome: The appeal is rejected. Alexion must bear the costs of the appeal proceedings.
- Official text on the court’s website (PDF): https://www.unified-patent-court.org/sites/default/files/files/api_order/FE0289FF2A1712A889FE017003D2B074_en.pdf

## How to cite

Court of Appeal, Alexion Pharmaceuticals, Inc. v Amgen Technology (Ireland) Unlimited Company and others, UPC CoA 405/2024, Order of 20 December 2024 (OSCOLA)

## Full summary

Read the full analyses for free — create a free account: https://pitch.law/academy/upc-court-of-appeal/upc-coa-405-2024-2024-12-20

Topics: [Provisional measures](https://pitch.law/academy/upc-court-of-appeal/topics/provisional-measures), [Validity and revocation](https://pitch.law/academy/upc-court-of-appeal/topics/validity), [Infringement and claim interpretation](https://pitch.law/academy/upc-court-of-appeal/topics/infringement)

## In the same case

- [Alexion Pharmaceuticals, Inc. v Amgen Technology (Ireland) Unlimited Company and others, UPC CoA 405/2024, 08-08-2024](https://pitch.law/academy/upc-court-of-appeal/upc-coa-405-2024-2024-08-08): A written pleading in UPC proceedings is served by the Registry through the Court's Case Management System (CMS), not by one party's lawyer sending it to the other side's lawyer through another electronic channel.

## More on provisional measures

- [Guardant Health, Inc. v Sophia Genetics SA and others, UPC CoA 49/2026, 05-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-49-2026-2026-11-05): The Court of Appeal set aside a EUR 600,000 award of representation costs because the successful party had backed it only with invoices reading "supply of legal services" and general assertions about complexity and urgency.
- [SharkNinja Operating LLC v Groupe SEB France and others, UPC CoA 61/2026, 21-08-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-61-2026-2026-08-21): The Court of Appeal overturned the Paris Local Division and granted SharkNinja a provisional injunction in France and Germany against SEB's "Cookeo Infinity" multicookers.
- [Amazon.com, Inc. and others v InterDigital VC Holdings, Inc. and others, UPC CoA 936/2025, 15-07-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-936-2025-2026-07-15): The Court of Appeal permitted InterDigital to withdraw its application for provisional measures against Amazon while Amazon's appeal was pending, and declared the proceedings closed.
- [AIM Sport Development AG v TGI Sport Suomi Oy and others, UPC CoA 108/2026, 08-07-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-108-2026-2026-07-08): The Court of Appeal's judge-rapporteur held that an appeal against a first-instance order disposing of an application for provisional measures is an appeal against a final decision under R 220.1(a) RoP, because R 363.2 RoP gives such orders that status.
- [Angelalign Technology Inc. and others v Align Technology, Inc., UPC CoA 36/2026, 08-07-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-36-2026-2026-07-08): The Court of Appeal rejected Angelalign's appeal and upheld the Düsseldorf preliminary injunction against the "Live Now" feature of its iOrtho orthodontic planning software.
